Risk of Arterial and Venous Thromboembolic Events with Bevacizumab, an Antibody against Vascular Endothelial Growth Factor A (VEGF-A): A Systematic Review and Meta-Analysis. Global Journal of Medical Research, [S. l.], v. 20, n. B1, p. 71–85, 2020. Disponível em: https://medicalresearchjournal.org/index.php/GJMR/article/view/1952. Acesso em: 13 aug. 2026.